Tag - pharmaceuticals

 
 

PHARMACEUTICALS

Construction is underway on a Project Stargate AI infrastructure site, a collaboration between three large tech companies — OpenAI, SoftBank, and Oracle — in Abilene, Texas, in April.
BUSINESS
Oct 5, 2025
Trump targets deals in pharma, AI, energy and mining before midterm elections
Washington is pursuing deals across up to 30 industries, involving dozens of companies deemed critical to national or economic security.
U.S. President Donald Trump speaks before signing executive orders in the Oval Office at the White House in Washington on Sept. 19.
BUSINESS / Economy
Sep 27, 2025
Trump’s 100% pharmaceutical tariffs won’t apply to Japan and EU
A U.S.-Japan joint statement says American tariff rates on Japanese drugs and semiconductors should not exceed those applied to others, including the EU.
Jared Baeten, Gilead Sciences' senior vice president and virology therapeutic area head, hopes regulatory approval elsewhere for lenacapavir as a preexposure prophylaxis — for reducing the risk of contracting HIV — could lead to real discussions toward ending HIV in Japan.
BUSINESS / Companies
Sep 22, 2025
Twice-a-year injection could make HIV prevention easier, developer argues
Without the need to take a daily pill, adherence could improve, says an executive from Gilead Sciences, which developed such an injection.
Tylenol for sale at a pharmacy in New York on Sept. 5
WORLD / Politics
Sep 22, 2025
Trump administration to link Tylenol to autism, report says
Officials plan to warn pregnant women against using the medication, one of the world’s most common, over-the-counter pain relievers, unless they have a fever.
Erectile dysfunction drug Cialis
JAPAN / Science & Health
Sep 19, 2025
Panel OKs first OTC sales of erectile dysfunction drug in Japan
Cialis is set to become the first erectile dysfunction treatment that can be purchased at drugstores in Japan.
A scientist looks at scans of grains at the Memory Centre at the Department of Readaptation and Geriatrics of the University Hospital (HUG) in Geneva, Switzerland, on June 6, 2023.
JAPAN / Science & Health / FOCUS
Sep 17, 2025
Japan’s front-line researchers see bright path ahead for dementia treatment
Four scientists at the forefront of dementia research speak about what kind of future they envision for people with the condition.
Takeda Pharmaceutical’s experimental narcolepsy drug shows significant improvement in late-stage trials, potentially targeting the root cause of the disorder.
JAPAN / Science & Health
Sep 9, 2025
Takeda nears first therapy for root cause of narcolepsy
Patients who took the drug, called oveporexton, for 12 weeks experienced increased daytime alertness and an overall improvement in quality of life.
A staff member works in the lab of Hobum Oleochemicals, a manufacturer that develops sustainable chemical raw materials derived from renewable plant oils, in Hamburg, Germany, on Aug. 25.
BUSINESS / Markets
Sep 4, 2025
Trump's tariffs threaten to choke European chemicals recovery
The sector has been grappling in recent years with high production costs after gas and power prices soared following Russia's invasion of Ukraine.
A partly-used, 10 gram bag of semaglutide powder made by China-based Sinopep-Allsino Biopharmaceutical, at a compounding pharmacy in Arlington, Virginia, in December 2024.
BUSINESS / Companies
Sep 3, 2025
Chinese companies turn to generics as patents expire on weight-loss drugs
U.S. regulators have restricted the sale of cheap copies of the drugs, slowing demand for raw ingredients Chinese firms supplied over the past two years.
Aska Pharmaceutical's emergency contraceptive pill Norlevo
JAPAN / Science & Health
Aug 31, 2025
Japan panel OKs nonprescription sales of morning-after pill
The panel also agreed that the product will be classified as a drug that must be taken in the presence of a trained pharmacist for safety reasons.
The health ministry is considering allowing nationwide pharmacy sales of emergency contraceptive pills without requiring age restrictions or parental approval.
JAPAN / Science & Health
Aug 28, 2025
Japan weighs OTC sales of emergency contraceptive pills without age limit
To ensure proper use, the plan would require that the morning-after pill be taken in the presence of a pharmacist.
Chugai Pharmaceutical shares sank as much as 20% in Tokyo on Friday after a study revealed that an obesity drug it licensed to Eli Lilly & Co. resulted in lower weight loss and higher rates of nausea and vomiting than anticipated.
BUSINESS / Companies
Aug 8, 2025
Chugai stock drops the most since 1977 on disappointing obesity drug data
A study showed the drug, which it has licensed to Eli Lilly & Co., resulted in lower weight loss and higher rates of nausea and vomiting than anticipated.
The price of Alzheimer's drug Lecanemab, codeveloped by Japanese drugmaker Eisai and U.S. industry peer Biogen, will be lowered to ¥97,277 for a 500-milligram bottle.
JAPAN / Science & Health
Aug 7, 2025
Japan approves price cut for Alzheimer's drug Lecanemab
The drug's price will be lowered to ¥97,277 for a 500-milligram bottle starting on Nov. 1.
Sumitomo Pharma applied to Japanese regulators for manufacturing and marketing authorization aimed at treating patients with advanced Parkinson's disease.
JAPAN / Science & Health
Aug 5, 2025
Drugmaker in Japan seeks approval for stem cell treatment for Parkinson's
A trial led by Kyoto University researchers indicated treatment using induced Pluripotent Stem cells was safe and successful in improving symptoms of the disease.
The newly developed drug, Adriana, is a groundbreaking painkiller, which works on a completely different mechanism to morphine and other existing synthetic opioids.
JAPAN
Aug 5, 2025
Kyoto University team develops pain reliever comparable to morphine
Morphine, often administered to cancer patients, can cause serious adverse effects such as breathing issues and addiction.
Kobayashi Pharmaceutical Chairman Yoshihito Ota speaks during an interview in Osaka last month.
BUSINESS / Companies
Aug 4, 2025
Kobayashi Pharmaceutical chairman vows corporate culture reform
Kobayashi Pharmaceutical achieved net profit growth for over 20 years from its stock market listing until the beni kо̄ji scandal emerged last year.
U.S. President Donald Trump steps on stage to deliver remarks at the Salute to America Celebration at the Iowa State Fairgrounds in Des Moines on July 3.
BUSINESS / Economy
Jul 19, 2025
Trump aims tariff double whammy at industries and nations by Aug. 1
In addition to measures on copper, the U.S. has discussed making announcements on lumber, chips, critical minerals and drugs, in that order, though this may change.
Researchers at the National Cancer Center Japan say a new type of gut bacteria named YB328 could help unlock the potential of cancer immunotherapy.
JAPAN / Science & Health
Jul 15, 2025
Japan researchers identify gut bacteria strain that boosts anticancer drugs
The discovery may help raise the success rate of a type of cancer treatment that currently works for only 20% of patients who receive it.
One of the early exemplars of Chinese innovation is a cell therapy that has shown promise to potentially cure a deadly blood cancer.
BUSINESS / Tech
Jul 14, 2025
China biotech’s stunning advance is changing the world’s drug pipeline
The number of novel drugs in China entering into development ballooned to over 1,250 last year, far surpassing the European Union.
The Astellas Pharma headquarters in Tokyo. A district court in Beijing will hand down a ruling on Wednesday for a Japanese employee of Astellas Pharma, who has been charged with espionage in China, according to sources.
JAPAN / Crime & Legal
Jul 11, 2025
Chinese court to issue ruling on Japanese businessman
While the Japanese employee of Astellas Pharma was indicted in August last year, the Chinese side has not disclosed details of his charges.

Longform

Growing families are being priced out of Tokyo’s condo market, forced to choose between downtown convenience and suburban space.
Is living in central Tokyo still affordable?